472 related articles for article (PubMed ID: 23798680)
21. SIRT2 inactivation reveals a subset of hyperacetylated perinuclear microtubules inaccessible to HDAC6.
Skoge RH; Ziegler M
J Cell Sci; 2016 Aug; 129(15):2972-82. PubMed ID: 27311481
[TBL] [Abstract][Full Text] [Related]
22. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.
Matsuyama A; Shimazu T; Sumida Y; Saito A; Yoshimatsu Y; Seigneurin-Berny D; Osada H; Komatsu Y; Nishino N; Khochbin S; Horinouchi S; Yoshida M
EMBO J; 2002 Dec; 21(24):6820-31. PubMed ID: 12486003
[TBL] [Abstract][Full Text] [Related]
23. Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition.
Gu S; Liu Y; Zhu B; Ding K; Yao TP; Chen F; Zhan L; Xu P; Ehrlich M; Liang T; Lin X; Feng XH
J Biol Chem; 2016 Mar; 291(10):5396-405. PubMed ID: 26763233
[TBL] [Abstract][Full Text] [Related]
24. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of HDAC6 attenuates endothelial barrier dysfunction induced by thrombin.
Saito S; Lasky JA; Guo W; Nguyen H; Mai A; Danchuk S; Sullivan DE; Shan B
Biochem Biophys Res Commun; 2011 May; 408(4):630-4. PubMed ID: 21531207
[TBL] [Abstract][Full Text] [Related]
26. Reduced microtubule acetylation in cystic fibrosis epithelial cells.
Rymut SM; Harker A; Corey DA; Burgess JD; Sun H; Clancy JP; Kelley TJ
Am J Physiol Lung Cell Mol Physiol; 2013 Sep; 305(6):L419-31. PubMed ID: 23873844
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors.
Bali P; Pranpat M; Bradner J; Balasis M; Fiskus W; Guo F; Rocha K; Kumaraswamy S; Boyapalle S; Atadja P; Seto E; Bhalla K
J Biol Chem; 2005 Jul; 280(29):26729-34. PubMed ID: 15937340
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Histone Deacetylase 6 by Tubastatin A Attenuates the Progress of Osteoarthritis via Improving Mitochondrial Function.
Zheng Y; Chen Y; Lu X; Weng Q; Dai G; Yu Y; Yu K; Gao W
Am J Pathol; 2020 Dec; 190(12):2376-2386. PubMed ID: 32926854
[TBL] [Abstract][Full Text] [Related]
29. Rutin increases alpha-tubulin acetylation via histone deacetylase 6 inhibition.
Çetin Ö; Sari S; Erdem-Yurter H; Bora G
Drug Dev Res; 2022 Jun; 83(4):993-1002. PubMed ID: 35266183
[TBL] [Abstract][Full Text] [Related]
30. Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation.
Di Fulvio S; Azakir BA; Therrien C; Sinnreich M
PLoS One; 2011; 6(12):e28563. PubMed ID: 22174839
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase 6 (HDAC6) is an independent deacetylase for alpha-tubulin.
Zhao Z; Xu H; Gong W
Protein Pept Lett; 2010 May; 17(5):555-8. PubMed ID: 19961433
[TBL] [Abstract][Full Text] [Related]
32. Overexpressed HDAC8 in cervical cancer cells shows functional redundancy of tubulin deacetylation with HDAC6.
Vanaja GR; Ramulu HG; Kalle AM
Cell Commun Signal; 2018 May; 16(1):20. PubMed ID: 29716651
[TBL] [Abstract][Full Text] [Related]
33. Acetylated α-tubulin K394 regulates microtubule stability to shape the growth of axon terminals.
Saunders HAJ; Johnson-Schlitz DM; Jenkins BV; Volkert PJ; Yang SZ; Wildonger J
Curr Biol; 2022 Feb; 32(3):614-630.e5. PubMed ID: 35081332
[TBL] [Abstract][Full Text] [Related]
34. HDAC6 controls the kinetics of platelet activation.
Sadoul K; Wang J; Diagouraga B; Vitte AL; Buchou T; Rossini T; Polack B; Xi X; Matthias P; Khochbin S
Blood; 2012 Nov; 120(20):4215-8. PubMed ID: 22955928
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction.
Wattanathamsan O; Chantaravisoot N; Wongkongkathep P; Kungsukool S; Chetprayoon P; Chanvorachote P; Vinayanuwattikun C; Pongrakhananon V
J Biomed Sci; 2023 Jan; 30(1):4. PubMed ID: 36639650
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
38. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
39. HDAC6 regulates mutant SOD1 aggregation through two SMIR motifs and tubulin acetylation.
Gal J; Chen J; Barnett KR; Yang L; Brumley E; Zhu H
J Biol Chem; 2013 May; 288(21):15035-45. PubMed ID: 23580651
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
